Suven Pharmaceuticals Ltd
Padmakumar R. Kaimal, Ph.D.
Vice President, Technology Alliance & Business Development
1100 Cornwall Road
Monmouth Junction, NJ 08852
Vice President, Business Development
Contact: Padmakumar R. Kaimal, Ph.D.
Since its founding in 1989, Suven Life Sciences has established its core competency in the development of small nitrogen containing Heterocycles such as pyrimidines, purines, indoles, and imidazoles. Adding to its renowned expertise in cyanation, more recently, Suven has also demonstrated its proficiency in Carbohydrate and Chiral chemistry including Pyrrols, tetrahydrofurans, sulfinamides, and sulfoxides. Over the years, Suven has striven to bring key technologies into commercial scale production, the latest success being the large-scale manufacture of chirally pure tert-butylsulfinamide (TBSA; Ellman’s reagent; 2-methyl-2-propanesulfinamide ), a powerful chiral auxiliary.
In addition, Suven Life Sciences provides services to leading Global Life Science and Fine Chemical majors, including, Custom Synthesis, Process R&D;, Scale up, Contract Manufacturing and APIs for regulatory filings, as part of its Contract Research and Manufacturing Services (CRAMS). To learn more about CRAMS and the other services Suven Life Sciences has to offer, please visit our website at www.suven.com
Product List: 131